Interactive graph

Cross-filter indexed evidence rows in this workspace snapshot. Catalogue statistics are listed separately—they describe source inventories, not association scores. Apache ECharts powers the charts (open runtime); paid charting SDKs were avoided for this read-only explorer.

Structured evidence navigator only; requires oncology review; not medical advice.

Partial snapshot: diseases capped at 500 · clinical_trials capped at 400

Indexed graph coverage

Entity catalogues mean CANTI knows diseases, targets, and drugs exist. Relationship graph rows are source-backed disease-target, target-drug, disease-drug, trial, and signal links. Full graph means relationship rows are indexed, not just catalogue names. Missing rows mean not indexed yet, not absence of evidence.

Native cross-filtering is available here and on the GBM Evidence Graph explorer (/diseases/glioblastoma). Relationship coverage still depends on indexed evidence rows.

RowTypeShown in dashboardIndexed in databaseSource total where known
Diseases indexedentity catalogue500capped view28,99528,513
Targets indexedentity catalogue1,000capped view77,15596,569
Drugs indexedentity catalogue1,000capped view29,076Not available
Disease-target links indexedrelationship graph1,000capped view6,284Not available
Target-drug links indexedrelationship graph864capped view15,390Not available
Disease-drug links indexedrelationship graph1,000capped view5,212Not available
Trial rows indexed (links pending)relationship graph400capped view543Not available
Derived signals indexedrelationship graph502502Not available

Counts are read from the bounded dashboard payload plus read-only database counts when available. Capped rows are shown as a dashboard slice, not a completeness claim.

Indexed edges (filtered)
1864
Diseases linked
0
Targets linked
1001
Drugs linked
861

Snapshot generated 2026-10-14 22:44:39 UTC.

Search & filters
Indexed source
Trial status

Evidence board

Click chart segments or rows to add them to your evidence board.

Signals are structured prompts for clinician discussion. They are not recommendations.

Signals are ordered by indexed relationship richness, not by clinical benefit.

Saved for this session

Selected cards

No selected cards yet. Use a chart segment, source filter, or relationship row to build a local board.

Prioritized signals

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

  • Linked drugTrial-linked
    ClinicalTrials.govrepoDBCANTI signal builder

    repoDB approved/indication context indexed.

Drug development phase
Molecule type
Drugs by link degree

Showing up to 100 rows · click to cross-filter

Mechanism / action (from drug ↔ target)

Weighted pills · click to toggle

Top targets (filtered degree)
Top diseases (filtered links)
Evidence sources & freshness

Indexed edge counts by the evidence source column · 5 catalogue metadata rows returned · operator log timestamps when service role is configured on the server.

Indexed edge totals

  • opentargets1000
  • repodb1000
  • chembl864

Signal tiers

  • Trial-linked29
  • Target-drug linked467
  • Caution context1
  • Catalogue identity only5
  • repoDB context12

Trial-linked and target-drug linked rows are prioritized over catalogue identity and evidence gaps. Evidence gap means not indexed yet, not absence of evidence.

Connector freshness

  • ChEMBLStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-16

  • ClinicalTrials.govStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-14

  • Open TargetsStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-14

  • repoDB-style importStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-16

  • GBM preloadStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-14

  • CANTI signal builderStale (last success more than 7 days ago)

    Last success (UTC): 2026-05-16

  • Power BI audit / importNo successful refresh recorded yet
Trial status context

Trial rows are grouped by registry status. Open trial status does not mean eligibility or suitability. Review with oncology team.

Bucket counts

  • 103
  • 103
  • 78
  • 80
  • 36

Prioritized trial rows

  • NCT07411690RECRUITING

    Open or active trials

  • NCT05775458RECRUITING

    Open or active trials

  • NCT05686798RECRUITING

    Open or active trials

  • NCT05768087RECRUITING

    Open or active trials

  • NCT05756985RECRUITING

    Open or active trials

  • NCT07389278NOT_YET_RECRUITING

    Open or active trials

  • NCT06831526RECRUITING

    Open or active trials

  • NCT05909618RECRUITING

    Open or active trials

  • NCT02177578ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT03477513ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06059690RECRUITING

    Open or active trials

  • NCT03115333ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT07552233RECRUITING

    Open or active trials

  • NCT03251027ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT07413796RECRUITING

    Open or active trials

  • NCT06672575RECRUITING

    Open or active trials

  • NCT02977780RECRUITING

    Open or active trials

  • NCT02685605ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06072586RECRUITING

    Open or active trials

  • NCT05653622RECRUITING

    Open or active trials

  • NCT02179086ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT07365280NOT_YET_RECRUITING

    Open or active trials

  • NCT03596086RECRUITING

    Open or active trials

  • NCT05106296RECRUITING

    Open or active trials

  • NCT02800486RECRUITING

    Open or active trials

  • NCT04221503ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT05956821RECRUITING

    Open or active trials

  • NCT07138001NOT_YET_RECRUITING

    Open or active trials

  • NCT06492486NOT_YET_RECRUITING

    Open or active trials

  • NCT06160596RECRUITING

    Open or active trials

  • NCT04863950RECRUITING

    Open or active trials

  • NCT07387666NOT_YET_RECRUITING

    Open or active trials

  • NCT05765812RECRUITING

    Open or active trials

  • NCT07493447NOT_YET_RECRUITING

    Open or active trials

  • NCT05708352RECRUITING

    Open or active trials

  • NCT06954636RECRUITING

    Open or active trials

  • NCT07457307NOT_YET_RECRUITING

    Open or active trials

  • NCT07141732RECRUITING

    Open or active trials

  • NCT04945148RECRUITING

    Open or active trials

  • NCT06710249RECRUITING

    Open or active trials

  • NCT04656535ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06558214RECRUITING

    Open or active trials

  • NCT07485049RECRUITING

    Open or active trials

  • NCT05460507RECRUITING

    Open or active trials

  • NCT03405792ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT05879367RECRUITING

    Open or active trials

  • NCT07521657NOT_YET_RECRUITING

    Open or active trials

  • NCT07052877NOT_YET_RECRUITING

    Open or active trials

  • NCT04590664RECRUITING

    Open or active trials

  • NCT04959500ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06556563RECRUITING

    Open or active trials

  • NCT06177964RECRUITING

    Open or active trials

  • NCT05241392ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT03897491ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT03630289ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT02649582ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT03452579ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT04991870RECRUITING

    Open or active trials

  • NCT06973096RECRUITING

    Open or active trials

  • NCT03152318ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06146725RECRUITING

    Open or active trials

  • NCT05843253RECRUITING

    Open or active trials

  • NCT04135807RECRUITING

    Open or active trials

  • NCT03970447RECRUITING

    Open or active trials

  • NCT02974621ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT07284628NOT_YET_RECRUITING

    Open or active trials

  • NCT06499831ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06850766RECRUITING

    Open or active trials

  • NCT06264388RECRUITING

    Open or active trials

  • NCT04003649ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06845020NOT_YET_RECRUITING

    Open or active trials

  • NCT03175224RECRUITING

    Open or active trials

  • NCT05120284ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT06835803RECRUITING

    Open or active trials

  • NCT04479696RECRUITING

    Open or active trials

  • NCT06691308NOT_YET_RECRUITING

    Open or active trials

  • NCT07552467RECRUITING

    Open or active trials

  • NCT07263438RECRUITING

    Open or active trials

  • NCT00268385ACTIVE_NOT_RECRUITING

    Open or active trials

  • NCT04214392ACTIVE_NOT_RECRUITING

    Open or active trials

Filtered relationship table

At most 100 rows from the filtered subgraph

KindDiseaseTargetDrugSourceEvidence type
Disease ↔ targetglioblastomaSLC20A2—opentargetsliterature
Disease ↔ targetglioblastomaCREBZF—opentargetsliterature
Disease ↔ targetglioblastomaMIR574—opentargetsliterature
Disease ↔ targetglioblastomaCRYBB2—opentargetsliterature
Disease ↔ targetglioblastomaRHOQ—opentargetsliterature
Disease ↔ targetglioblastomaDMRT3—opentargetsliterature
Disease ↔ targetglioblastomaPDE3B—opentargetsliterature
Disease ↔ targetglioblastomaSIK2—opentargetsliterature
Disease ↔ targetglioblastomaH2BC1—opentargetsliterature
Disease ↔ targetglioblastomaSRRM4—opentargetsliterature
Disease ↔ targetglioblastomaSLC38A5—opentargetsliterature
Disease ↔ targetglioblastomaCKAP2—opentargetsliterature
Disease ↔ targetglioblastomaOGFOD1—opentargetsliterature
Disease ↔ targetglioblastomaFERRY3—opentargetsliterature
Disease ↔ targetglioblastomaHLF—opentargetsliterature
Disease ↔ targetglioblastomaAGFG2—opentargetsliterature
Disease ↔ targetglioblastomaTNKS2—opentargetsliterature
Disease ↔ targetglioblastomaCCNA1—opentargetsliterature
Disease ↔ targetglioblastomaMIR522—opentargetsliterature
Disease ↔ targetglioblastomaOSBPL3—opentargetsliterature
Disease ↔ targetglioblastomaRPS9—opentargetsliterature
Disease ↔ targetglioblastomaC1QTNF6—opentargetsliterature
Disease ↔ targetglioblastomaSEPHS2—opentargetsliterature
Disease ↔ targetglioblastomaATG4D—opentargetsliterature
Disease ↔ targetglioblastomaFOXO6—opentargetsliterature
Disease ↔ targetglioblastomaIGHV4-28—opentargetsliterature
Disease ↔ targetglioblastomaIGHV4-61—opentargetsliterature
Disease ↔ targetglioblastomaMAP3K12—opentargetsliterature
Disease ↔ targetglioblastomaELOB—opentargetsliterature
Disease ↔ targetglioblastomaIGHV1-58—opentargetsliterature
Disease ↔ targetglioblastomaBMP6—opentargetsliterature
Disease ↔ targetglioblastomaTCEA3—opentargetsliterature
Disease ↔ targetglioblastomaTCEA1—opentargetsliterature
Disease ↔ targetglioblastomaTBX5—opentargetsliterature
Disease ↔ targetglioblastomaTXNDC12—opentargetsliterature
Disease ↔ targetglioblastomaST8SIA4—opentargetsliterature
Disease ↔ targetglioblastomaLRP8—opentargetsliterature
Disease ↔ targetglioblastomaJDP2—opentargetsliterature
Disease ↔ targetglioblastomaMT-RNR1—opentargetsliterature
Disease ↔ targetglioblastomaNTN3—opentargetsliterature
Disease ↔ targetglioblastomaACSL1—opentargetsliterature
Disease ↔ targetglioblastomaCA5A—opentargetsliterature
Disease ↔ targetglioblastomaCERS1—opentargetsliterature
Disease ↔ targetglioblastomaCDC73—opentargetsliterature
Disease ↔ targetglioblastomaCOL20A1—opentargetsliterature
Disease ↔ targetglioblastomaCTDSP2—opentargetsliterature
Disease ↔ targetglioblastomaCHRNA1—opentargetsliterature
Disease ↔ targetglioblastomaPOLE4—opentargetsliterature
Disease ↔ targetglioblastomaCGB5—opentargetsliterature
Disease ↔ targetglioblastomaRPS27L—opentargetsliterature
Disease ↔ targetglioblastomaNNT—opentargetsliterature
Disease ↔ targetglioblastomaDENND2D—opentargetsliterature
Disease ↔ targetglioblastomaDCLRE1C—opentargetsliterature
Disease ↔ targetglioblastomaAHNAK2—opentargetsliterature
Disease ↔ targetglioblastomaFUT6—opentargetsliterature
Disease ↔ targetglioblastomaMEGF10—opentargetsliterature
Disease ↔ targetglioblastomaLSINCT5—opentargetsliterature
Disease ↔ targetglioblastomaPCP4—opentargetsliterature
Disease ↔ targetglioblastomaTMTC4—opentargetsliterature
Disease ↔ targetglioblastomaFAT2—opentargetsliterature
Disease ↔ targetglioblastomaPLA2R1—opentargetsliterature
Disease ↔ targetglioblastomaGNB1—opentargetsliterature
Disease ↔ targetglioblastomaGGA2—opentargetsliterature
Disease ↔ targetglioblastomaPTCHD1—opentargetsliterature
Disease ↔ targetglioblastomaTRBC2—opentargetsliterature
Disease ↔ targetglioblastomaTNFAIP8—opentargetsliterature
Disease ↔ targetglioblastomaAPOBEC3A—opentargetsliterature
Disease ↔ targetglioblastomaACO2—opentargetsliterature
Disease ↔ targetglioblastomaPHYHIPL—opentargetsliterature
Disease ↔ targetglioblastomaKMO—opentargetsliterature
Disease ↔ targetglioblastomaDPM1—opentargetsliterature
Disease ↔ targetglioblastomaKLF13—opentargetsliterature
Disease ↔ targetglioblastomaBCRP1—opentargetsliterature
Disease ↔ targetglioblastomaSORCS3—opentargetsliterature
Disease ↔ targetglioblastomaMIR20A—opentargetsliterature
Disease ↔ targetglioblastomaIGHV3-73—opentargetsliterature
Disease ↔ targetglioblastomaEFNA2—opentargetsliterature
Disease ↔ targetglioblastomaAAR2—opentargetsliterature
Disease ↔ targetglioblastomaMTMR14—opentargetsliterature
Disease ↔ targetglioblastomaSLC7A6—opentargetsliterature
Disease ↔ targetglioblastomaCAVIN3—opentargetsliterature
Disease ↔ targetglioblastomaPOM121L9P—opentargetsliterature
Disease ↔ targetglioblastomaPYM1—opentargetsliterature
Disease ↔ targetglioblastomaS1PR4—opentargetsliterature
Disease ↔ targetglioblastomaPITRM1—opentargetsliterature
Disease ↔ targetglioblastomaSLC6A1—opentargetsliterature
Disease ↔ targetglioblastomaRAD54B—opentargetsliterature
Disease ↔ targetglioblastomaSMS—opentargetsliterature
Disease ↔ targetglioblastomaMLLT3—opentargetsliterature
Disease ↔ targetglioblastomaMINCR—opentargetsliterature
Disease ↔ targetglioblastomaORAI3—opentargetsliterature
Disease ↔ targetglioblastomaMYLIP—opentargetsliterature
Disease ↔ targetglioblastomaDNAJB11—opentargetsliterature
Disease ↔ targetglioblastomaMIR595—opentargetsliterature
Disease ↔ targetglioblastomaZKSCAN3—opentargetsliterature
Disease ↔ targetglioblastomaC12ORF75—opentargetsliterature
Disease ↔ targetglioblastomaCBY1—opentargetsliterature
Disease ↔ targetglioblastomaMT1JP—opentargetsliterature
Disease ↔ targetglioblastomaDARS2—opentargetsliterature
Disease ↔ targetglioblastomaLINC01426—opentargetsliterature

Structured evidence navigator only; requires oncology review; not medical advice.